Diabetes and its management
Rohit thanage
What is diabetes
What is diabetes?
Diabetes mellitus, commonly referred to simply as diabetes, is a metabolic disease that causes high
blood sugar.
The hormone insulin moves sugar from the blood into your cells to be stored or used for energy. With
diabetes, your body either doesn’t make enough insulin or can’t effectively use the insulin it does
make.
Types of diabetes
There are a few different types of diabetes:
•Type 1: Type 1 diabetes is an autoimmune disease. The immune system attacks and destroys cells in the
pancreas, where insulin is made. It’s unclear what causes this attack.
•Type 2: Type 2 diabetes occurs when your body becomes resistant to insulin, and sugar builds up in your
blood. It’s the most common type—about 90% to 95%Trusted Source of people living with diabetes have type
2.
•Gestational: Gestational diabetes is high blood sugar during pregnancy. Insulin-blocking hormones produced
by the placenta cause this type of diabetes.
Prediabetes
Prediabetes is the term that’s used when your blood sugar is
higher than expected, but it’s not high enough for a diagnosis of
type 2 diabetes. It occurs when the cells in your body don’t
respond to insulin the way they should. This can lead to type 2
diabetes down the road.
General symptoms
The general symptoms of diabetes include:
•increased hunger
•increased thirst
•weight loss
•frequent urination
•blurry vision
•extreme fatigue
•sores that don’t heal
Diabetes Pathophysiology
Triad to Ominous Octet
Hepatic Peripheral
Glucose Production
Insulin Secretion (-cell)
Glucose Utilization
(liver)
(muscle)
Traditional Triad Ominous octet
Metabolic-Cardio-Renal Continuum*
*Adapted from original CV Risk Continuum: Dzau VJ, Braunwald E. Am Heart J. 1991 Apr;121(4 Pt 1):1244-63
Insulin is the main treatment for type 1 diabetes. It replaces the
hormone your body isn’t able to produce.
Various types of insulin are commonly used by people with type
1 diabetes. They differ in how quickly they start to work and
how long their effects last:
•Rapid-acting insulin: starts to work within 15 minutes and its
effects last for 2 to 4 hours
•Short-acting insulin: starts to work within 30 minutes and
lasts 3 to 6 hours
•Intermediate-acting insulin: starts to work within 2 to 4 hours
and lasts 12 to 18 hours
•Long-acting insulin: starts to work 2 hours after injection and
lasts up to 24 hours
•Ultra-long acting insulin: starts to work 6 hours after
injection and lasts 36 hours or more
•Premixed insulin: starts working within 5 to 60 minutes and
lasts 10 to 16 hours
Drug How it works Examples
alpha-glucosidase inhibitors slow your body’s breakdown of acarbose (Precose) and miglitol
sugars and starchy foods
biguanides reduce the amount of glucose your metformin (Glucophage, Riomet)
liver makes
alogliptin (Nesina), linagliptin
DPP-4 inhibitors improve your blood sugar without (Tradjenta), saxagliptin (Onglyza),
making it drop too low and sitagliptin (Januvia)
stimulate your pancreas to produce semaglutide (Ozempic), dulaglutide
glucagon-like peptides more insulin; slow stomach (Trulicity), exenatide (Byetta), and
emptying liraglutide (Victoza)
meglitinides stimulate your pancreas to release nateglinide and repaglinide
more insulin
canagliflozin (Invokana),
SGLT2 inhibitors release more glucose into the urine dapagliflozin (Farxiga), and
empagliflozin (Jardiance)
stimulate your pancreas to release glyburide (Glynase), glipizide
sulfonylureas more insulin (Glucotrol), and glimepiride
(Amaryl)
thiazolidinediones help insulin work better pioglitazone (Actos) and
rosiglitazone
What are the comparisons between the available T2D
treatment options?
Metformin SU TZD DPP-4i SGLT2i GLP-1 RA Insulin
Efficacy High High High Intermediate Intermediate High Highest
Risk of Low Moderate Low Low Low Low High
hypoglycaemia
Weight Loss Gain Gain Neutral Loss Loss Gain
Oedema, HF, Genital
Side effects GI Hypo fractures Rare Infections GI Hypo
DPP-4i, dipeptidyl peptidase-4 inhibitor; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HF, heart failure; SGLT2i, sodium-glucose co-transpoter-2 inhibitor; SU, sulphonylurea; T2D, type 2 diabetes; TZD, thiazolidinedione
ADA. Diabetes Care 2020;43:S1
8
lippincott
Thank you